A recent study published in Cell reveals that the repeated DNA sequence that leads to Huntington’s disease (HD) expands ...

H.C. Wainwright analyst Patrick Trucchio has reiterated their bullish stance on QURE stock, giving a Buy rating on January 21.Invest with ...

Subtle signs of neurodegeneration can be detected in blood, CSF, and neuroimaging, up to 20 years before the motor symptoms ...

Teva Pharmaceutical Industries reported a slightly larger than expected rise in fourth-quarter profit, helped by double-digit ...

Mitochondria are crucial organelles for cellular homeostasis, regulating processes such as ATP production, reactive oxygen species (ROS) management and Ca2+ signaling.

H.C. Wainwright analyst Patrick Trucchio raised the firm’s price target on uniQure (QURE) to $70 from $25 and keeps a Buy rating on the shares.

A drug originally developed for high blood pressure could find a new use in the treatment of Huntington's disease, thanks to an artificial intelligence-based drug discovery programme at Spain's ...

Prilenia Therapeutics is planning to file its Huntington’s disease therapy pridopidine in the EU, despite mixed results in a phase 3 trial. Pridopidine is an oral agonist of the S1R protein ...

Buc-ee's filed a lawsuit against a smaller Texas-based gas station chain on allegations of copyright infringement, claiming Super Fuels' logo is too similar to the Buc-ee's logo. The lawsuit filed ...

For proof, look no further than the colors it chooses for the Super Bowl logo. The premise of the alleged conspiracy is that the colors in the NFL's official Super Bowl logo correspond to the ...

The Huntington Town Board is considering a request by Huntington-based Hunebed Holdings LLC to have RozeWood Farm and Estate included in the town’s Historic Building Overlay District.